Opportunities for Early-Stage Start-up investment in times of economic uncertainty

Sydney Angels is still investing in startups with high potential. “There’s a lot of negative speculation around whether early-stage tech companies will get the funding needed to rapidly grow, given the huge uncertainty facing investors. "Tech startups are an extremely important sector of the economy and will drive a significant portion of Australia’s economic recovery. We believe it’s more crucial than ever to support early-stage companies with capital for growth..." Adrian Bunter from Sydney Angels speaks to Startup Daily. about the opportunities for early-stage start up investment in times of economic uncertainty.

Atomo Diagnostics lists on the ASX

Sydney Angels portfolio company Atomo Diagnostics listed on the ASX (ASX:AT1) on 16 April. A few far sighted Sydney Angels members invested in Atomo starting back in 2010 - and their investment has been worth it - with the closing price on the first day representing more than 10x return on investment (based on the closing price of $0.39). Congratulations to Atomo and its investors. Atomo is a global leader in pathology on a stick diagnostic kits and has achieved remarkable success, especially with its HIV test in developing countries without a network of pathology labs. One of its key investors is the Bill & Melinda Gates Foundation.